Follow-up, treatment, and reinfection rates among asymptomatic Chlamydia trachomatis cases in general practice by Valkengoed, I.G.M. van et al.
Original papers
British Journal of General Practice, August 2002 623
Follow-up, treatment, and reinfection
rates among asymptomatic Chlamydia
trachomatis cases in general practice
Irene G M van Valkengoed, Servaas A Morré, Adriaan J C van den Brule, Chris J L M Meijer, Lex M Bouter,
Jacques Th M van Eijk and A Joan P Boeke
Introduction
GENITAL infection with Chlamydia trachomatis is themost prevalent sexually transmitted infection in The
Netherlands, as well as in other industrialised countries.1
Since it causes no or few symptoms, many infections remain
undetected. An untreated infection in women may lead to
pelvic inflammatory disease (PID), and at a later stage to
infertility, ectopic pregnancy, and chronic abdominal pain.2
Infected women can pass the infection on to their children at
birth.4 Complications in men are less severe, but the screen-
ing and treatment of men is important in limiting the spread
of the infection. 
Scholes et al have shown that screening for asymptomatic
infections in women leads to a reduction of 56% in the inci-
dence of PID.2 To date, most screening programmes have
been opportunistic, aimed at patients attending various
types of clinics or in specific high-risk groups. The introduc-
tion of sensitive DNA detection methods on non-invasively
collected specimens, such as urine,5-6 and the use of post-
ed samples obtained at home enables screening beyond
the traditional settings.7-8
Various pilot studies have been conducted in general
practice throughout Europe to detect asymptomatically
infected individuals.9-11 Adequate treatment and follow-up of
patients is essential to the success of any screening pro-
gramme. C trachomatis infections can be treated effectively
with a single dose of azithromycin.12 However, reports from
clinics for sexually transmitted diseases (STDs) suggest that
the follow-up of infected individuals may not always be suc-
cessful.13 However, this may not be applicable to asympto-
matically infected patients in general practice where the fol-
low-up rates may be better, since there is often a longstand-
ing relationship of trust with the physician.
Another important factor in the success of a screening
programme is the number of reinfections that occur during
follow-up, which determines how often screening should be
repeated in a certain setting. Research in schools and STD
clinics in the United States has reported reinfection rates
varying from between 6% and 15% within one year.14-16 This
rate is probably lower in the general population, although no
specific data are available.
The main objective of our research was to study the rates
of diagnostic confirmation of C trachomatis infection, suc-
cessful treatment, and reinfection one year after asympto-
matic infections were detected in a screening programme in
general practice.
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SUMMARY
Background: Adequate treatment and follow-up of patients is
essential to the success of a screening programme for Chlamydia
trachomatis. There has been a lack of data on follow-up, confir-
mation of infections, and reinfection rates among asymptomatic
patients in general practice.
Aim: To study the rates of diagnostic confirmation of C tra-
chomatis infection, successful treatment, and reinfection one year
after cases were detected in a screening programme for asympto-
matic infections. 
Design of study: Prospective cohort study. 
Setting: Fifteen general practices in Amsterdam, The
Netherlands.
Method. One hundred and twenty-four patients with asympto-
matic C trachomatis infections were requested to provide a cervi-
cal or urethral swab and a urine specimen, for the purpose of
diagnostic confirmation before being treated. One year after the
first screening, all of the patients were invited for a second
screening. All samples were tested using the ligase chain reaction
(Abbott Laboratories, Chicago, USA).
Results: Out of 124 patients, 110 (89%) attended the scheduled
appointment for diagnostic confirmation and treatment; 92
(84%) of them were confirmed to be positive and received treat-
ment. At the second screening a year later, none of the 56
patients who had received treatment and who had been screened
a second time were reinfected.
Conclusion: No asymptomatic patients were found to have rein-
fections with C trachomatis one year after diagnostic confirma-
tion and treatment. This underlines the effectiveness of the
screening and treatment strategy.
Method
Between January 1997 and December 1998, 124 men and
women were screened and tested positive for an asympto-
matic C trachomatis infection. All cases were detected in a
study of 11 005 men and women between the ages of 15
and 40 years of age, who were randomly selected from the
computerised registers of 15 general practices in
Amsterdam and invited to participate in a large screening
programme for asymptomatic C trachomatis infection. All
practices had been selected based on previous research
experience with the co-ordinating research institute (EMGO
Institute). The practices were spread throughout the city,
such that all districts of Amsterdam were represented in the
study. Participants in the screening were requested to return
by post a urine specimen obtained at home and a complet-
ed questionnaire containing questions on demographic vari-
ables, current urogenital symptoms, history of STDs, and
sexual behaviour.9 The participation rate was 33% for men
and 51% for women. All participants were considered to be
asymptomatic, even though mild genitourinary complaints
were reported by a large proportion of the screened popu-
lation. However, these symptoms were not recognised as
signs of infection and, as a consequence, patients did not
consult a physician and did not believe themselves to be at
risk of an infection. 
Participants were compared with non-participants on sev-
eral demographic variables. Participants were found to be
similar to non-participants with regard to marital status, type
of health insurance and age. However, participants were
more likely than non-participants to be of Dutch origin.9 The
prevalence of infection was 2.4% among men and 2.8%
among women. The screening results were reported back to
the general practice in which the patient was registered. The
general practitioner (GP) was requested to invite all infected
patients to attend an appointment at the surgery. They
received either a written invitation or a telephone call,
depending on the preference they had stated in the ques-
tionnaire. They were informed that an infection had been
found and that it was very important to make an appoint-
ment for diagnostic confirmation and eventual treatment.
Those who did not respond to the initial notification within
two weeks received a reminder telephone call from their
physician. 
At the time of the visit to the surgery, patients were invited
by the GP to participate in the follow-up study, as well as a
partner notification procedure. They were assured that they
would receive adequate treatment, regardless of whether or
not they decided to participate.
A cervical swab was taken from female patients and a ure-
thral swab from male patients, and a second urine specimen
was collected. The screening results were considered to be
confirmed if at least one of the two specimens was again
positive for C trachomatis. The treatment consisted of a sin-
gle dose of 1000 mg azithromycin, or erythromycin for preg-
nant women (4 × 500 mg for five days). Partners were noti-
fied, as described elsewehere.9,17
Detection of C trachomatis 
All samples obtained during the study were tested for the
presence of C trachomatis DNA by means of the ligase chain
reaction (LCR) test (Abbott Laboratories, Chicago, Illinois,
USA) in the laboratory of the Department of Pathology of the
Academic Hospital Vrije Universiteit. Tests were performed
according to the instructions of the manufacturer and the
results of all tests were reported back to the practice where
the patient was registered. 
Test of cure
Patients were requested to return four weeks after receiving
treatment, when another urine sample was obtained. If the
patient tested positive again, it was ascertained whether the
patient had taken the medication and whether current sexu-
al partners had been tested and treated. If not, the patient
was instructed to take the treatment and to notify partners
that they should receive adequate treatment. If it was likely
that the positive test result was owing to treatment failure, a
seven-day course of doxycycline was prescribed and the
patient was requested to come back again one month later.
Follow-up after one year
One year after the patients were last seen by the GP and
tested negative, or one year after the estimated date if the
patient had not had a test of cure, a package for the follow-
up screening test was sent to their current home address. All
the correspondence was sent from the practice by the GP to
ensure confidentiality and anonymity of the patients. The
package contained an information leaflet, a short question-
naire, a urine container and a disposable glove. The patient
was requested to collect a urine sample and to answer
seven questions on the questionnaire about current com-
plaints, number of new sexual partners, treatment, and part-
ner notification after the last screening. They were request-
ed to send the coded urine sample and questionnaire to the
Department of Pathology in a prepaid envelope which was
included in the package. A single written reminder was sent
by the GP if the package had not been returned within four
weeks of the posting date. The test results were reported
back to the general practice where the patient was regis-
tered. General practitioners were requested to provide ade-
quate follow-up and treatment, if indicated.
Statistical analysis 
The percentage of patients contacted for diagnostic confir-
mation and treatment was determined, and determinants of
non-attendance were investigated. The results of the confir-
matory tests and factors correlating to the discrepancy of
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HOW THIS FITS IN
What do we know?
No specific data were available on the 
success of follow-up and reinfection rates after
screening for asymptomatic infections in general practice. 
What does this paper add?
In this study it was shown that, with adequate follow-up, the
reinfection rates among asymptomatic cases within one year
are low. 
these results with the original screening test were evaluated.
The percentages of participation in the test of cure and the
rate of successful treatment were determined.
The participation rate and rate of reinfection with C tra-
chomatis (percentages) were determined after one year. The
data were analysed using the SPSS package version 7.5.2.
Crude odds ratios (ORs) with 95% confidence intervals (CIs)
were calculated for all associations. Where appropriate, χ2
tests were used.
Results
Figure 1 shows a flow-chart of the follow-up study. Of the
124 cases detected in the initial screening, 110 (89%)
responded to the invitation for an appointment with their GP
and were thus eligible to participate in the follow-up study.
None of those who did not respond to the invitation gave a
reason for not attending. All eligible patients agreed to par-
ticipate in the first part of the follow-up study, the diagnostic
confirmation test and the test of cure. Being of
Surinam/Antillean origin was positively associated with non-
attendance. Patients under 25 years of age, patients with no
current genitourinary complaints, and patients who had
completed less than 16 years of education seemed to have
lower attendance rates. However, confidence intervals of all
associations were wide and included a value of 1. 
Ninety-two (84%) of the 110 patients who were tested
again were confirmed to be positive and were treated for C
trachomatis infection. No associations were found with
young age, gender, reported complaints, Surinam/Antillean
origin, multiple sexual partners, having had an STD, incon-
sistent condom use, level of education or marital status
(data not shown).
All treated patients were requested to return for a test of
cure. Sixty-two (67%) of the 92 patients who had been treat-
ed participated in the test of cure. No associations were
found with young age, gender, reported complaints,
Surinam/Antillean origin, multiple sexual partners, history of
STD, inconsistent condom use, level of education or marital
status (data not shown). Five (8%) patients were tested pos-
itive and were treated again for the infection. All of them
reported that they had complied with the initial treatment. 
One year after treatment, the 92 treated patients were
invited to participate in the second screening. Fifty six (61%)
participated. Of the non-participants, two explicitly refused
further participation in the study and nine could not be con-
tacted because their current address was unknown. The rest
did not participate for other or unknown reasons. Patients
who had had a test of cure participated in the second
screening more frequently than those who had not (odds
ratio = 5.0 [95% CI = 2.4 to 10.1]). Age at the time of the first
screening, gender, reported complaints, Surinam/Antillean
origin, multiple sexual partners, having had an STD prior to
the first screening, inconsistent condom use, level of educa-
tion and marital status were not associated with participation
(Table 2). Of the patients participating in the second screen-
ing, 53 (95%) reported that they had been treated for infec-
tion after the initial screening. Thirty eight (68%) stated that
they were certain that all their sexual partners had been noti-
fied and tested after the initial screening. Fourteen (25%)
patients reported that they had a new sexual partner since
the last screening. None of the participants in the second
screening tested positive for C trachomatis infection.
Discussion
Attendance
In this study we have described what happens after a posi-
tive screening test for an asymptomatic C trachomatis infec-
tion. Of all the positive patients, 11% did not respond to the
invitation for an appointment for diagnostic confirmation and
treatment. This rate is similar to the rates reported in other
settings.13,18,19 Attendance for diagnostic confirmation and
treatment is an important factor that must be taken into con-
sideration in the evaluation of a screening programme
because it relates directly to its effectiveness, particularly in
terms of cost. This is often neglected.20,21 Untreated patients
remain at risk of developing complications, such as PID,
tubal factor infertility, and ectopic pregnancy2,22 and risk
spreading the infection to their sexual partners. 
To increase the number of patients treated, the computer
files of the patients who did not attend could be marked, so
that the GP is reminded of the positive screening test result
the next time this patient shows up at the surgery for any
reason. The GP would then have the opportunity to discuss
the likelihood of infection with the patient during the visit,
and to offer diagnostic confirmation and eventual treatment.
Attendance among patients of Surinam/Antillean origin was
lower than among patients of other origins. This finding may
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Figure 1. Flow chart of follow-up cases with an asymptomatic
Chlamydia trachomatis infection after screening.
Contacted for diagnostic
confirmation and treatment
n = 110
Non-responder
n = 14
Cases first screening
n = 124
Test of cure
n = 62
No test of cure
n = 30
No Chlamydia
n = 18
Study participant
n = 110
Refusal
n = 0
Second screening
n = 56
Lost to follow up:
— registered with
different practice
— refusal
— other reasons
be relevant for practice if it can be confirmed in future stud-
ies. It should be taken into account that it may be a chance
finding, and may be owing to multiple comparisons used in
the present study in an attempt to identify potentially rele-
vant determinants of attendance. 
Confirmation
In the present study, 18 of the positive screening tests could
not be confirmed, suggesting that 16% of the positive
screening tests were false positives. The specificity of the
LCR test on urine is estimated to be around 99%.5,7 In a low
prevalence population, as in the present study,9 this speci-
ficity may lead to a substantial number of false positives.
Given the potential consequences for a patient of positive
test results, which may be inaccurate; e.g. the effect on rela-
tionships and the possible side effects of treatment, we rec-
ommend that in a controlled environment, such as a gener-
al practice surgery, the screening test result should be con-
firmed before offering treatment and notifying partners.
Test of cure
Five patients were still positive after the test of cure, although
all of them reported that they had been treated. This finding
could be explained by treatment failure or by reinfection of
the patients by an untreated partner. However, most patients
reported that they had only one steady partner, and the
majority of these steady partners were contacted and treat-
ed for infection.17 Another possible explanation is that the
test detected non-viable DNA, although reports suggest that
a period of four weeks should be enough to clear the infec-
tion after treatment.23 It has to be noted that a routine test of
cure is currently not included in the recommendations on
the management of C trachomatis infections.24,25
Reinfection
No participants in the second screening were found to be
reinfected, although the study population was considered to
be at high risk of infection, based on the fact that they were
diagnosed with an asymptomatic C trachomatis infection at
the first screening. The absence of reinfections underscores
the fact that the general population is at low risk of acquiring
a C trachomatis infection. 
A limitation of this study is that only 61% of the patients
were screened a second time. Although no major differ-
ences were found among participants and non-participants
of the second screening, it should be taken into account that
possibly only those patients who lead more stable sexual
lives participated. 
Patients who did not have a test of cure — a determinant
of participation in the second screening — could potentially
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Table 2. Determinantsa associated with non-participation in a second screening one year after cases were detected in a screening pro-
gramme for asymptomatic Chlamydia trachomatis infections in general practice.
Determinant Prevalence of determinant (%) Crude OR (95% CI)
Non-participants Participants
(n = 36) (n = 56) 
Male sex 48 28 2.40 (0.96–5.80)  
Age ≤25 years 24 29 0.80 (0.46–1.70)  
Surinam/Antillean origin 15 20 0.71 (0.22–2.30)  
Married or cohabiting  61 65 0.84 (0.34–2.00)  
Having at least 16 years of education  59 57 1.10 (0.42–2.60)  
Inconsistent condom use 58 71 0.56 (0.23–1.40)  
History of STD 25 18 1.50 (0.52–4.30)  
Current genitourinary complaints 30 46 0.50 (0.20–2.00)  
Changing sexual contacts 18 31 0.50 (0.17–4.00)  
aDeterminants as classified at the time of the first screening test. 
Table 1. Determinants associated with the attendance for diagnostic confirmation and treatment after a positive screening test result for
asymptomatic Chlamydia trachomatis infections in general practice.
Determinant Prevalence of determinant (%) Crude OR (95% CI)
Non-participants Participants
(n = 14) (n = 110)
Male sex  29 35 1.10 (0.31–1.80)  
Age ≤25 years 42 28 0.54 (0.16–1.80)  
Surinam/Antillean origin 50 16 0.19 (0.05–0.66)  
Married or cohabiting  50 66 1.90 (0.59–6.50)  
Having at least 16 years of education 83 66 0.25 (0.05–1.20)  
Inconsistent condom use 46 65 2.20 (0.62–7.70)  
History of STD 18 19 1.00 (0.21–5.20)  
Current genitourinary complaintsa 67 38 0.31 (0.09–1.10)  
Changing sexual contacts 36 24 0.56 (0.15–2.10)  
aMild genitourinary complaints were reported by a large proportion of the population. However, symptoms were not recognised as a sign of infec-
tion and a physician was not consulted; these cases were therefore considered to be asymptomatic.
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have suffered treatment failure. This could have led to high-
er estimated reinfection rates, since C trachomatis infection
is assumed to persist if left untreated.26
Detection of C trachomatis in the second screening was
based on an LCR test on urine. Various studies, which have
been reported in the literature, found reduced sensitivities
for the LCR test on urine, especially for women. The sensi-
tivity on urine for women is estimated to be between 85%
and 95%.5-7 Based on this, some infections among the
women who participated in the second screening could
have been missed. At the same time, with a low incidence or
prevalence of infection, as mentioned previously, some
false-positive test results would be expected to occur. This
was not the case.
Training
The GPs who participated in our study had only a small
amount of specific postgraduate training for the follow-up of
patients with chlamydial infection. In one session they were
instructed on how to obtain a cervical or urethral swab and
had the procedure for the follow-up explained. After the study
it was often reported by the GPs that the consultations for
diagnostic confirmation and treatment had been very
demanding, especially since the infection was diagnosed
unexpectedly in most patients. They stressed the need for
specific training in how to present the test results and how to
discuss the potential physical and social consequences of
the infection. This result confirms findings from a qualitative
study that staff outside specialised services may require guid-
ance on providing support to women diagnosed with infec-
tion,27 since health advisors have an important role in com-
municating the results, giving advice, and providing reassur-
ance.27,28 If screening were to be implemented, this should
be an important element in the implementation strategy.
To summarise, no reinfections with C trachomatis were
found among asymptomatic cases one year after diagnostic
confirmation and treatment. Despite the small study size,
this clearly underlines the effectiveness of the screening and
treatment strategy and underscores the fact that the gener-
al population is at relatively low risk of acquiring a C tra-
chomatis infection. 
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